findmyKOL
Clinical trialNCT00454818CompletedPhase 1/PHASE2Interventional

Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

SponsorCelladon CorporationEnrollment51Dilated CardiomyopathyHeart Failure, Congestive
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Diego Cardiac Center

    San Diego, California, United States

  • University of California at San Diego Medical Center

    San Diego, California, United States

  • Shands Hospital at University of Florida

    Gainesville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Chicago Medical Center

    Chicago, Illinois, United States

  • Mid America Heart Institute, Saint Luke'S Hospital

    Kansas City, Missouri, United States

  • St. Louis University Hospital

    St Louis, Missouri, United States

  • University of Medicine and Dentistry of New Jersey

    Newark, New Jersey, United States

  • Columbia University Hospital

    New York, New York, United States

  • Mount Sinai Medical Center

    New York, New York, United States

  • Wake Forest University

    Winston-Salem, North Carolina, United States

  • University of Cincinnati

    Cincinnati, Ohio, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Metrohealth Medical Center

    Cleveland, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center, Presbyterian-Shadyside Hospital

    Pittsburgh, Pennsylvania, United States

  • Tennessee Center for Clinical Trials & Harton Regional Medical Center

    Tullahoma, Tennessee, United States

  • Cardiopulmonary Research Science and Technology Institute, Medical City Dallas Hospital

    Dallas, Texas, United States

  • Methodist Hospital

    Houston, Texas, United States

  • Intermountain Medical Center

    Murray, Utah, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2007
Primary completion
31 Aug 2010
Completion
31 Aug 2012
Last update posted
20 Aug 2014
Registered enrollment
51
Registry id
NCT00454818

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.